baber/WOPTO huggingface dataset:
Patent CA-2595287-A1 (CA)
Inventor: VAN DOORN LEENDERT JAN
IPC: C12Q1/70
Filed: 2006-01-17
Abstract: A method for identification of an HPV16 lineage group in a sample, comprising contacting such nucleic acid simultaneously with three probes, each probe being capable of specific hybridization across positions 143 and 145 of a HPV  16 genome.
Patent CA-2596228-A1 (CA)
Inventor: KING RICHARD
IPC: B25B27/02
Filed: 2006-04-10
Abstract: Apparatus (4) for removing a sealing plug from a bore (11) , which sealing plug comprises an outer sleeve (13) and an inner stem (14) retained within the outer sleeve, the removal taking place after a suitable hole has been drilled part of the way into the stem, which removal apparatus (4) comprises a tapered punch (15) for forcible insertion into the hole in the stem (14) thereby to create an interference fit between the punch (15) and the stem (14) and thereafter driving the stem (14) out of the sleeve (13) whilst also retaining the stem (14) on the punch (15) by virtue of the interference fit, and sleeve-engaging means (16) engagable with the sleeve (13) after the punch (15) has removed the stem (14) from the sleeve (13) , the sleeve-engaging means (16) and the punch (15) being thereafter removable from the bore thereby to remove both the sleeve (13) and the stem (14) from the bore whilst the sleeve (13) and the stem (14) are both retained on the appropriate parts of the apparatus.
Patent CA-2598941-A1 (CA)
Title: Methods and compositions for the in-situ thermal stimulation of hydrocarbons using peroxide-generating compounds
Inventor: FUNKHOUSER GARY P
IPC: E21B43/25
Filed: 2006-02-14
Abstract: One embodiment provides a method for stimulating hydrocarbon production in a subterranean formation, comprising: introducing a peroxide-generating compound into a desired location in a subterranean formation, wherein the peroxide-generating compound is substantially mechanically isolated from the subterranean formation until the peroxide- generating compound reaches the desired location; and allowing the peroxide-generating compound to generate peroxide in the desired location in the subterranean formation. Another embodiment provides a method for stimulating hydrocarbon production in a subterranean formation, comprising: introducing a peroxide-generating compound into a desired location in a subterranean formation, wherein the peroxide-generating compound further comprises a chemical moderator that acts to inhibit the reaction of the hydrogen peroxide within the subterranean formation; and later, allowing the peroxide-generating compound to generate peroxide in the desired location in the subterranean formation. Another embodiment provides a treatment fluid for stimulating hydrocarbon production from a subterranean formation, comprising peroxide-generating compound and a moderator.
Patent CA-2599265-A1 (CA)
Inventor: SCALLON BERNARD
IPC: C12N15/00
Filed: 2006-02-24
Abstract: The invention relates to methods for making modified immunoglobulin compositions to maximize antigen binding and effector function by swapping of sequences of the heavy and light chains within an IgG Fab domain for the purpose of reorienting the Fc domain relative to the antigen-binding domain.
Patent CA-2599918-A1 (CA)
Inventor: MONMA TSUKASA
IPC: G02C13/00
Filed: 2006-02-28
Abstract: An oil-repellent coating layer (2) is provided on both surfaces of a lens material (1) comprising glass or a plastic. A fine particle layer (3), which contains at least one of fine particles of a metal oxide and fine particles of a fluoride being dispersed therein, is formed on the surface of the oil-repellent coating layer (2), and further a resin layer (4) comprising an organic compound is provided on the surface of the fine particle layer (3).  The resin layer (4) exhibits good close attachment to a double-coated adhesive tape which is used when the lens is set onto an edger, which results in reducing the probability of the occurrence of deviation of axes during working.
Patent CA-2601717-A1 (CA)
Title: Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof
Inventor: UNOKI GEN
IPC: A61P3/10
Filed: 2006-03-17
Abstract: A pyrazolopyrimidine derivative represented by the general formula (I) and a pharmaceutically acceptable salt thereof exhibits excellent MAPKAP-K2 inhibitory activity. A pharmaceutical agent comprising the compound as the active ingredient is expected to be useful for the treatment of MAPKAP-K2-mediated disorders including inflammatory disorders, autoimmune disease, destructive bone disorders, cancer and/or tumor growth.
Patent CA-2602431-A1 (CA)
Inventor: LI WEN
IPC: H01M8/10
Filed: 2006-03-29
Abstract: Improved polymer-based materials are described, for example for use as an electrode binder in a fuel cell. A fuel cell according to an example of the present invention comprises a first electrode including a catalyst and an electrode binder, a second electrode, and an electrolyte located between the first electrode and the second electrode. The electrolyte may be a proton-exchange membrane (PEM). The electrode binder includes one or more polymers, such as a polyphosphazene.
Patent CA-2603324-A1 (CA)
Inventor: PECK JAMES
IPC: B65D85/38
Filed: 2006-03-29
Abstract: A contact lens package has a body with a lens receptacle therein covered by a hinged lid. The lid is offset on the body such that a ledge is formed by the base and an overhang by the lid. The ledge has a plurality of upstanding lugs that insert into mating receptacles formed in the overhang of an adjacent contact lens package, permitting the ganging of packages together for functional and aesthetic reasons.
Patent CA-2604281-A1 (CA)
Title: Nanoparticulate and controlled release compositions comprising prostaglandin derivatives
Inventor: JENKINS SCOTT
IPC: A61K9/14
Filed: 2006-04-13
Abstract: The present invention is directed to compositions comprising a nanoparticulate prostaglandin derivative, preferably limaprost or a salt or derivative thereof, having improved bioavailability. The nanoparticulate prostaglandin derivative particles of the composition have an effective average particles size of less than about 2000 nm and are useful in the treatment of ischemic symptoms. The invention also relates to a controlled release composition comprising a prostaglandin derivative, such as limaprost alfadex, or a nanoparticulate prostaglandin derivative, such as limaprost or a salt or derivative thereof, that in operation delivers the drug in a pulsed or bimodal manner for the treatment of ischemic symptoms.
Patent CA-2604831-A1 (CA)
Inventor: BEKELE SOLOMON
IPC: B32B27/32
Filed: 2006-03-28
Abstract: A coextruded multilayer film includes a core layer including an ethylene vinyl alcohol copolymer; two intermediate layers each including a blend of an amorphous polyamide having a glass transition temperature of at least 80~ C, and a semicrystalline polyamide; two outer layers each including an olefinic polymer; and two tie layers each adhering an intermediate layer to a respective outer layer; wherein the film exhibits an elongation at yield (ASTM  D 882) of less than 15% in each of the longitudinal and transverse directions, and a free shrink (ASTM D 2732) at 200~F of less than 8% in each of the longitudinal and transverse directions. An aseptic package includes a sterilized food product, and a sterilized pouch in which the sterilized food product is disposed, the sterilized pouch including the coextruded multilayer film of the invention. A method of making an aseptic package is also disclosed.
Patent CA-2607002-A1 (CA)
Inventor: TAKENAKA TORU
IPC: B60W10/18
Filed: 2006-08-07
Abstract: A control means 10 for controlling operations of actuators 3A, 3B, and 3C of a vehicle 1 creates a time series of a future behavior of the vehicle 1 by using a vehicle model 41. At this time, a state amount of the vehicle model 41 is initialized on the basis of a state amount of the actual vehicle 1, and the future behavior is created starting from the initial state amount. The future behavior is created such that operation commands of the actuators in the vehicle model 41 at the current time coincide with or approximate to basic values based on an operation of a manipulating device 5, such as a steering wheel of the vehicle 1. It is evaluated whether evaluation objects, such as a vehicle motion, a road surface reaction force, and wheel sliding, in the created future behavior satisfy predetermined restrictive conditions. Based on the evaluation result, the operation commands of the actuators 3A, 3B, and 3C are successively decided. This permits an ideal travel of the vehicle to be achieved by properly predicting future behaviors of the vehicle.
Patent CA-2610646-A1 (CA)
Title: Prevascularized devices and related methods
Inventor: WILLIAMS STUART K
IPC: A61K35/44
Filed: 2006-06-02
Abstract: The present invention provides an implantable devices for providing a biologically active agent to a subject in need thereof, the device comprising a microvessel construct in contact with a biocompatible, semi-permeable pouch, the pouch encapsulating a cell or cells capable of producing the biologically active agent. The present invention also provides methods for treating or preventing a disorder in a subject using the implantable device. The present invention also provides specific methods for treating or preventing diabetes in a subject comprising implanting in the subject an immunoisolation device comprising a microvessel construct in contact with a biocompatible, semi-permeable pouch, the pouch encapsulating a cell or cells capable of producing a therapeutically effective amount of insulin. Methods for vascularizing and revascularizing tissue, including engineered tissue, are also provided.
Patent CA-2613146-A1 (CA)
Inventor: KINNUNEN PAAVO
IPC: B01L99/00
Filed: 2006-06-21
Abstract: The present invention is directed to a method and a device for forming an interface between a first and a second essentially immiscible liquid, especially for the measurement of the surface tension at said interface.  According to the invention, a volume of the first liquid is added to a first well having a closed bottom, walls and an upper opening in a horizontal surface. A volume of the second liquid is added to a second well, e.g. in the form of a bore or a sleeve having an upper well opening and a lower well opening which lower well opening rests in a sealing relationship on the said horizontal surface, the said surface closing the lower opening, but in sliding engagement therewith. The lower opening of the second well is brought into alignment with the upper opening of the first well, thus depositing the volume of the second liquid on top of the surface of the volume of the first liquid, to form the desired liquid-liquid interface.
Patent CA-2614335-A1 (CA)
Title: Secure rfid packaging
Inventor: DEWAN SUNIL
IPC: G08B13/14
Filed: 2006-07-06
Abstract: Methods and systems are provided for preparing radio-frequency devices for secure distribution. Multiple such radio-frequency devices are received. Each device has an embedded radio-frequency transponder. Each radio-frequency devices is moved sequentially to stations of a preparation device. At a first station, a radio-frequency identification code assigned to the radio-frequency device is encoded to personalize the radio-frequency device with recipient-specific radio-frequency identification data. At a second station, the radio-frequency devices is packaged within a package such that the radio-frequency device within the package is electromagnetically shielded at radio frequencies.
Patent CA-2614378-A1 (CA)
Title: Dispositif generateur de plasma, dispositif chirurgical au plasma et utilisation d'un dispositif chirurgical au plasma
Inventor: SUSLOV NIKOLAY
IPC: H05H1/34
Filed: 2006-07-07
Abstract: La présente invention concerne un dispositif générateur de plasma comprenant une anode, une cathode et un canal de plasma qui, dans sa direction longitudinale, s'étend au moins partiellement entre la cathode et l'anode. L'extrémité de la cathode qui est tournée vers l'anode comporte une pointe de cathode se rétrécissant en direction de l'anode, une partie de cette pointe de cathode s'étendant sur une longueur partielle d'une chambre de plasma reliée au canal de plasma. La chambre de plasma comporte une surface de section transversale perpendiculaire à la direction longitudinale du canal de plasma qui est supérieure à la surface de section transversale perpendiculaire à la direction longitudinale du canal de plasma d'une ouverture, la plus proche de la cathode, du canal de plasma. Cette invention concerne également un dispositif chirurgical au plasma et l'utilisation d'un tel dispositif chirurgical au plasma.
Patent CA-2614982-A1 (CA)
Inventor: MATHESON GEORGE E
IPC: F21V23/06
Filed: 2006-07-13
Abstract: The present invention provides a modular panel lighting apparatus comprising a multi layer power board and one or more lighting modules. The power board is a compound structure of one or more electrically conductive layers which are separated by one or more electrically insulating layers. The power board is configured to receive one or more lighting modules and can provide electrical, mechanical and thermal function adequate to meet a desired functionality of the lighting apparatus. A lighting module comprises one or more light-emitting elements operatively attached to a connector element that has one or more electrical contact portions. By inserting the connector element into the power board, the lighting module can be mounted anywhere on the face of the power board. When appropriately inserted into the power board, the one or more electrical contact portions of the connector element can establish selective electrical contact with the conductive layers of the power board and can secure the lighting module in place.
Patent CA-2615260-A1 (CA)
Title: Limited slip differential for electric vehicle
Inventor: CLARK WARREN
IPC: A63B55/60
Filed: 2007-12-19
Abstract: An electric vehicle, such as a golf car or utility vehicle, is provided with an electric motor that provides dynamic braking for the vehicle. The vehicle drivetrain is provided with a limited slip differential in order to prevent the wheels from turning freely when traction is lost.
Patent CA-2618618-A1 (CA)
Title: Food product slicer with carriage drive
Inventor: SHARIFF SHAHRAM
IPC: B26D7/06
Filed: 2006-08-02
Abstract: A food product slicer (10) with a food carriage drive (28, 33) is provided.  The drive (28, 33) includes a manual assist mode that is responsive to operator applied force.
Patent CA-2618736-A1 (CA)
Title: Chemical process
Inventor: HALL ROGER GRAHAM
IPC: C07D275/03
Filed: 2006-08-18
Abstract: This invention relates to a process for the preparation of compounds of formula (I) Where Ra, Rb, R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are defined organic groups, the process comprising reactions a compound of formula (II) with a compound of formula (III) RcCHO and an oxidising agent.
Patent CA-2618944-A1 (CA)
Inventor: DAS PRALAY K
IPC: E21B41/00
Filed: 2003-03-26
Abstract: A replaceable battery pack for a downhole tool in a wellbore comprises a housing adapted to be insertably extractable in a cavity on an external surface of the downhole tool. The housing is sized to fit substantially flush with a substantially uniform outer diameter of the downhole tool and is adapted to be extracted from the downhole tool without further disassembling the downhole tool. An electrical power cell is disposed in the housing. An electrical system is disposed in the downhole tool disengageably engaged to the replaceable battery pack for receiving power from the replaceable battery pack. A seal is disposed in a groove in the housing. The seal acts cooperatively with the housing and a surface of the cavity to capture a volume at atmospheric pressure thereby forming a pressure lock when exposed to a downhole pressure. The pressure lock acts to hold the housing in the cavity.
Patent CA-2619402-A1 (CA)
Inventor: KRUEGER THOMAS
IPC: C07C233/13
Filed: 2006-08-10
Abstract: The invention relates to a method for producing betamimetics of formula (I), (see formula 1) in which n represents 1 or 2; R1 represents hydrogen, halogen, C1-4 alkyl or O-C1-4 alkyl; R2 represents hydrogen, halogen, C1-4 alkyl or O-C14 alkyl, and; R3 represents hydrogen, C1-4 alkyl, OH, halogen, O-C1-4 alkyl, O-C1-4 alkylene-COOH, O-C1-4 alkylene-COO-C14-alkyl.
Patent CA-2619481-A1 (CA)
Title: Methods for the treatment of anxiety and for identification of anxiolytic agents
Inventor: BEYER CHAD EDWARD
IPC: A61K38/095
Filed: 2006-08-23
Abstract: Methods for the treatment of neuropsychiatric disorders such as anxiety are disclosed. The methods involve modulating the expression of the angiotensin IV  receptor or modulating the biological activity of the angiotensin IV receptor by utilizing antagonists to the receptor. Also disclosed are methods for identifying antagonists of the angiotensin IV receptor that are effective to reduce anxiety in a subject.
Patent CA-2619851-A1 (CA)
Inventor: BEIER NORBERT
IPC: A61K31/4188
Filed: 2006-08-02
Abstract: The invention relates to novel squaric acid compounds of formula (I), wherein R1, R2, R2', R2'' and X have the designations cited in patent claim 1. Said compounds can be inhibitors of CHK1 CHK2 and SGK kinases, and can be used to treat diseases and illnesses such as cancer, diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonal hypertonia, cardiovascular diseases and kidney diseases, generally for all types of fibroses and inflammatory processes.
Patent CA-2619949-A1 (CA)
Title: Method and apparatus for detecting a wireless communication network in overlapping frequency bands
Inventor: MITTAL VINEET
IPC: H04W48/18
Filed: 2006-08-18
Abstract: Techniques for efficiently performing system search to obtain service from a wireless system as quickly as possible are described. A terminal initially looks for service from a first (e.g., W-CDMA) system. The terminal identifies network(s) in the first system from which service was received in the past and performs acquisition on each network to look for service. If service is not found for the first system, then the terminal performs a search for a second (e.g., GSM) system. If service is found on the second system, then the terminal obtains service from the second system and avoids a frequency scan for the first system. Otherwise, the terminal performs a frequency scan for the first system using the search results for the second system. The terminal may obtain a list of RF channels detected for the second system and may omit these RF channels and possibly some other RF channels around these RF channels from the frequency scan.
Patent CA-2619975-A1 (CA)
Title: Wear assembly for excavating machines
Inventor: STITZEL ADAM
IPC: E02F9/28
Filed: 2006-08-28
Abstract: A wear member that includes a pair of legs defining a slot straddles the digging edge of a piece of excavating equipment. In one construction, the sl ot is formed at its front end with a pair of inclined surfaces and a laterally extending ridge that is fit within a complementary channel on the digging edge. A lock is received within an opening in the wear member to releasably secure the wear member to the digging edge.
Patent CA-2620219-A1 (CA)
Title: Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
Inventor: HIBI TORU
IPC: A61K9/68
Filed: 2006-10-17
Abstract: Organoleptically acceptable solid oral dosage formulations of ibuprofen, and methods of making and using the same, are provided. A feature of the subject formulations is that they include ibuprofen and a masking component. In certain embodiments, the masking component includes one or more of a cooling agent, an organic acid and a cyclodextrin. The subject invention finds use in a variety of applications.
Patent CA-2623600-A1 (CA)
Title: Crystalline forms of atorvastatin
Inventor: SCHOENING KAI-UWE
IPC: A61P43/00
Filed: 2001-12-19
Abstract: The present invention is directed to new crystalline forms of Atorvastatin calcium (2:1), referred to hereinafter as polymorphic Forms X, A, B, B2, C, D and E.  Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms.
Patent CA-2623616-A1 (CA)
Inventor: KARMARKAR PARAG V
IPC: A61N1/18
Filed: 2006-11-29
Abstract: MRI compatible localization and/or guidance systems for facilitating placement of an interventional therapy and/or device in vivo include: (a) a mount adapted for fixation to a patient; (b) a targeting cannula with a lumen configured to attach to the mount so as to be able to controllably translate in at least three dimensions; and (c) an elongate probe configured to snugly slidably advance and retract in the targeting cannula lumen, the elongate probe comprising at least one of a stimulation or recording electrode. In operation, the targeting cannula can be aligned with a first trajectory and positionally adjusted to provide a desired internal access path to a target location with a corresponding trajectory for the elongate probe. Automated systems for determining an MR scan plane associated with a trajectory and for determining mount adjustments are also described.
Patent CA-2625001-A1 (CA)
Title: Infant formulas containing docosahexaenoic acid and lutein
Inventor: BARRETT-REIS BRIDGET
IPC: A23L33/00
Filed: 2006-10-23
Abstract: Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.
Patent CA-2626067-A1 (CA)
Title: Biologically excitable cells
Inventor: MARBAN EDUARDO
IPC: A61K48/00
Filed: 2006-10-16
Abstract: As an alternative strategy to electronic pacemaker devices, we explored the feasibility of converting normally-quiescent ventricular myocytes into pacemakers by somatic cell fusion. The idea is to create chemically-induced fusion between myocytes and syngeneic fibroblasts engineered to express HCN1 pacemaker ion channels (HCN1 fibroblasts), in normally-quiescent myocardium.  HCN1-expressing fibroblasts formed stable heterokaryons with myocytes, generating spontaneously-oscillating action potentials as well as ventricular pacemaker activity in vivo and provides a platform for an autologous, non-viral, adult somatic cell therapy. We also converted a depolarization-activated potassium-selective channel, Kv1.4, into a hyperpolarization-activated non-selective channel by site-directed mutagenesis (R447N, L448A, and R453I in S4 and G528S in the pore). Gene transfer into ventricular myocardium demonstrated the ability of this construct to induce pacemaker activity, with spontaneous action potential oscillations in adult ventricular myocytes and idioventricular rhythms by in vivo electrocardiography. Given the sparse expression of Kv1 family channels in the human ventricle, gene transfer of a synthetic pacemaker channel based on the Kv1 family has therapeutic utility as a biological alternative to electronic pacemakers.
Patent CA-2627548-A1 (CA)
Inventor: TURNBULL CLIFFORD W
IPC: B05B7/30
Filed: 2006-10-25
Abstract: Disposable reservoirs for use with spray apparatuses, reservoir-adapter kits, spray assemblies employing such reservoirs, and methods of use are disclosed.
Patent CA-2628049-A1 (CA)
Inventor: WALDON DAN
IPC: C09D121/00
Filed: 2007-07-19
Abstract: A coating composition is disclosed, comprising a binder component having hydroxyl-functional groups; a curing agent having functional groups, wherein the functional groups of the curing agent are reactive with the hydroxyl-functional groups of the binder component; and pulverized rubber, the pulverized rubber having particles with a size suitable for spraying the coating.